DENALI THERAPEUTICS INC's ticker is DNLI and the CUSIP is 24823R105. A total of 208 filers reported holding DENALI THERAPEUTICS INC in Q4 2023. The put-call ratio across all filers is 0.82 and the average weighting 0.2%.
Quarter-by-quarter ownership
| Value | Shares | Weighting | ||||
|---|---|---|---|---|---|---|
| Q2 2024 | $668,490 | +101.3% | 29,642 | +83.1% | 0.00% | – |
| Q1 2024 | $332,108 | -8.8% | 16,188 | -4.2% | 0.00% | – |
| Q4 2023 | $363,978 | +1.3% | 16,892 | -3.1% | 0.00% | – |
| Q3 2023 | $359,377 | +15.7% | 17,427 | +28.6% | 0.00% | – |
| Q1 2023 | $310,644 | +21.6% | 13,553 | +45.0% | 0.00% | – |
| Q4 2022 | $255,550 | +6.9% | 9,349 | +21.8% | 0.00% | – |
| Q3 2022 | $239,000 | – | 7,674 | – | 0.00% | – |
Download | ||||||
Other shareholders
| Name | Shares | Value | Weighting ↓ |
|---|---|---|---|
| Crestline Management, LP | 19,462,500 | $404,042,000 | 54.41% |
| Bratton Capital Management, L.P. | 953,035 | $19,785,000 | 29.05% |
| Flagship Pioneering Inc. | 8,005,747 | $166,199,000 | 7.19% |
| Casdin Capital, LLC | 400,000 | $8,304,000,000 | 0.78% |
| Temasek Holdings (Private) Ltd | 4,410,457 | $91,561,000 | 0.65% |
| IRONWOOD INVESTMENT MANAGEMENT LLC | 22,595 | $469,000 | 0.37% |
| MARK ASSET MANAGEMENT LP | 70,532 | $1,464,000 | 0.34% |
| Artal Group S.A. | 400,000 | $8,304,000 | 0.34% |
| PIER 88 INVESTMENT PARTNERS LLC | 27,650 | $574,000 | 0.24% |
| WASATCH ADVISORS LP | 996,147 | $20,680,000 | 0.20% |